Identification |
Name: | Quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione,6,7-dihydro-7-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-,(7S)- |
Synonyms: | Quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione,6,7-dihydro-7-[[2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-,[2S-[2a,9b,9(R*),9ab]]-; 1H-Imidazo[1,2-a]indole, quinazolino[3,2-a][1,4]benzodiazepine-5,13-dionederiv.; (-)-Asperlicin; Asperlicin |
CAS: | 93413-04-8 |
Molecular Formula: | C31H29 N5 O4 |
Molecular Weight: | 0 |
InChI: | InChI=1/C31H29N5O4/c1-17(2)15-22-29(39)36-25-14-8-5-11-20(25)31(40,30(36)34-22)16-23-26-32-21-12-6-3-9-18(21)28(38)35(26)24-13-7-4-10-19(24)27(37)33-23/h3-14,17,22-23,30,34,40H,15-16H2,1-2H3,(H,33,37)/t22-,23-,30-,31-/m0/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | 1.48g/cm3 |
Refractive index: | 1.761 |
Flash Point: | °C |
Safety Data |
|
|